Healthcare

Novo Nordisk surges after U.S. regulators approve the first GLP-1 pill, while shares of rival pharma giant Eli Lilly decline.

While the S&P 500 has gained 17% so far this year, it has been outstripped by an overseas index.

Shares are down significantly, but the valuation and growth story remain compelling.

Vaxcyte keeps its place among Mizuho Securities top picks entering 2026.

At Friday’s news conference announcing the latest drug-pricing deals, Trump said he wants health insurers to ‘ease up and start cutting prices’ as well.

The company makes drugs for pets and farm animals. Shares are up 84% this year.

Shares in memory-chip makers Micron and Sandisk rally after Micron tops Wall Street's earnings estimates.

Health-savings accounts are expanding to more Americans. How to make the most of them.

Ann Miletti, head of investments at Allspring Global Investments, says her team finds plenty of stocks to like in unloved parts of the market.

The biopharmaceutical company said it was discontinuing development of a drug treating a chronic sinus condition.

Micron Earnings Impress Wall Street, Trump’s prediction of an economic boom may be wrong, more news to start your day.

The medical supply firm raised $6.3 billion at a market value of $54.5 billion.

Tesla drops after setting a record closing high, while Lennar tumbles following weak earnings for the home builder.

By forcing a vote on an extension, GOP lawmakers are both offering enrollees hope for price cuts and acknowledging the party’s Achilles heel.

The decision comes less than two weeks after a committee of advisers to the agency, whom Robert F. Kennedy Jr. appointed this year, voted to change their decades-old guidance.

Bostic says Fed should pause rate cuts, Warner Bros. to tell shareholders to reject Paramount bid, Medline set to trade in IPO, and more news to start your day.

Shares of Tesla close on a record high.

Pfizer expects revenue and earnings to fall in 2026.

George Renaudin, president of its insurance segment, will retire by the third quarter of 2026.

GE Vernova manufactures turbines, which excited no one when the spinoffs were announced. But now the company is up some 400% making house-size turbines to power data centers.

New York City logged the first “very high” flu activity reading of the year, raising concerns about the season ahead.

2025 has been the worst year for measles in the U.S. since 1992.

Americans without health insurance could be paying more than 10 times as much for the weight-loss drugs.

Lawmakers are still battling over how to address expiring subsidies that help cover the costs of healthcare plans offered through the Affordable Care Act.

Medical technology, services, and equipment companies are gaining in strength.